Omega 3 fatty acid for the prevention of cognitive decline and dementia (Q24202649)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22696350 AND SRC:MED&resulttype=core&format=json

5 February 2020

meta-analysis

0 references

title

Omega 3 fatty acid for the prevention of cognitive decline and dementia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22696350 AND SRC:MED&resulttype=core&format=json

5 February 2020

0 references

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22696350 AND SRC:MED&resulttype=core&format=json

5 February 2020

Alan D. Dangour

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22696350 AND SRC:MED&resulttype=core&format=json

5 February 2020

Wee Shiong Lim

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22696350 AND SRC:MED&resulttype=core&format=json

5 February 2020

2

Alan D Dangour

0 references

author name string

Wee-Shiong Lim

series ordinal

3

0 references

publication date

13 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22696350 AND SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22696350 AND SRC:MED&resulttype=core&format=json

5 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22696350 AND SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

CD005379

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22696350 AND SRC:MED&resulttype=core&format=json

A randomised controlled trial investigating the effect of n-3 long-chain polyunsaturated fatty acid supplementation on cognitive and retinal function in cognitively healthy older people: the Older People And n-3 Long-chain polyunsaturated fatty acid

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

n-3 fatty acids and cardiovascular events after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

Effect of fish oil supplementation on quality of life in a general population of older Dutch subjects: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy ol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

DHA may prevent age-related dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

Global prevalence of dementia: a Delphi consensus study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

Dietary factors and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

Current concepts in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

Mild cognitive impairment: conceptual basis and current nosological status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

Gene expression analysis in human fetal retinal explants treated with docosahexaenoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

Nutrition in brain development and aging: role of essential fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

Omega 3 fatty acid for the prevention of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

Omega 3 fatty acid for the prevention of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

7 January 2021

Rey's verbal learning test: normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

7 January 2021

Normative data for the Animal, Profession and Letter M Naming verbal fluency tests for Dutch speaking participants and the effects of age, education, and sex.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

7 January 2021

Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

7 January 2021

Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005379.PUB3

7 January 2021

10.1002/14651858.CD005379.PUB3

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22696350 AND SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017